T. Chiu

Phenomic Analysis of Chronic Granulomatous Disease Reveals More Severe Integumentary Infections in X-Linked Compared With Autosomal Recessive Chronic Granulomatous Disease

Chung Y. Wong, D. Lung, Tong-Xin Chen, 2022, Frontiers in Immunology.

Immune-related Adverse Effects Associated with Programmed Death-1 Inhibitor Therapy in the Treatment of Non-Small Cell Lung Cancer: Incidence, Management, and Effect on Outcomes.

R. Hui, R. Cooper, F. Niu, 2020, The Permanente journal.

Evaluation of the safety and effectiveness of switching from standard to extended interval dosing for durvalumab in unresectable stage III non-small cell lung cancer.

R. Hui, D. Shen, Stephanie Mac, 2021, Journal of Clinical Oncology.